Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments
- PMID: 3311151
- DOI: 10.1021/bi00389a008
Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the gamma-chain. Sequence of carboxy-terminal cyanogen bromide gamma-chain fragments
Abstract
Puff adder venom contains a protease capable of cleaving the gamma-chain of cross-linked D-dimer, derived from the plasmin digestion of fibrin, into apparently symmetrical monomers. The cross-linked gamma-chains are separated in the process without apparent loss of mass and without loss of the substituent at the glutamine cross-link site, if fluorescent D-dimer (the lysine analogue dansylcadaverine used as substituent) is used as substrate [Purves, L. R., Purves, M., Lindsey, G. G., & Linton, N. J. (1986) S. Afr. J. Sci. 82, 30]. The gamma-chain from puff adder venom digested D-monomer was isolated and cleaved by cyanogen bromide, and the carboxy-terminal peptide was isolated and sequenced. The carboxy-terminal peptide composition indicated a lower content of histidine, leucine, and glycine than expected. Manual microsequencing by gas-phase Edman degradation demonstrated that two amino-terminal ends were present. By use of the known sequence of the human fibrinogen gamma-chain, the sequencing data could be resolved into a dipeptide cross-linked between lysine-406 and either glutamine-398 or -399 (residues 6 and 13 or 14 from the carboxy-terminal end of the gamma-chain) with the loss of residues 401-404 that occur between the cross-link sites of both antiparallel cross-linked gamma-chains. D-dimer is therefore separated into monomers by cleavage of the gamma-chain between the cross-link sites. Two symmetrical fragments are produced consisting of a cross-linked dipeptide with the loss of four amino acids.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.J Biol Chem. 1988 Sep 25;263(27):13848-56. J Biol Chem. 1988. PMID: 2971046
-
A re-examination of the cleavage of fibrinogen and fibrin by plasmin.J Biol Chem. 1975 Sep 25;250(18):7210-8. J Biol Chem. 1975. PMID: 126232
-
Kinin-releasing enzyme from the venom of Bitis arietans (puff adder).Biochim Biophys Acta. 1986 Dec 10;884(3):502-9. doi: 10.1016/0304-4165(86)90201-1. Biochim Biophys Acta. 1986. PMID: 3535900
-
Amino acid sequence studies on the alpha chain of human fibrinogen. Isolation and characterization of two linked alpha-chained cyanogen bromide fragments from fully cross-linked fibrin.Biochemistry. 1977 Apr 19;16(8):1715-9. doi: 10.1021/bi00627a030. Biochemistry. 1977. PMID: 851527
-
Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen beta-chain: homology with the corresponding gamma-chain peptide and presence in fragment D.Biochim Biophys Acta. 1975 Apr 29;386(2):617-22. doi: 10.1016/0005-2795(75)90306-2. Biochim Biophys Acta. 1975. PMID: 124585
Cited by
-
The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10511-6. doi: 10.1073/pnas.95.18.10511. Proc Natl Acad Sci U S A. 1998. PMID: 9724734 Free PMC article.
-
Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization.Protein Sci. 1999 Dec;8(12):2663-71. doi: 10.1110/ps.8.12.2663. Protein Sci. 1999. PMID: 10631982 Free PMC article.
-
Localization of transglutaminase-reactive glutamine residues in bovine osteopontin.Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):13-6. doi: 10.1042/bj3040013. Biochem J. 1994. PMID: 7998923 Free PMC article.
-
New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.Med Sci (Basel). 2018 Oct 8;6(4):87. doi: 10.3390/medsci6040087. Med Sci (Basel). 2018. PMID: 30297644 Free PMC article. Review.
-
Mass Spectrometric Identification of a Novel Factor XIIIa Cross-Linking Site in Fibrinogen.Proteomes. 2021 Nov 2;9(4):43. doi: 10.3390/proteomes9040043. Proteomes. 2021. PMID: 34842803 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources